Peripheral tissue-resident memory T cells evidenced by markers such as CD103, CD69 and CXCR6 elicited a robust cellular immunity by recruiting and activating cytotoxic CD8 T cells and NK cells in a PD-L1 blockade treatment tumor mouse model (111). This evidence concerns the gene CD8A and neoplasm.